These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35913160)

  • 1. Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection.
    P Tavares L; Brüggemann TR; M Rezende R; G Machado M; Cagnina RE; Shay AE; C Garcia C; Nijmeh J; M Teixeira M; Levy BD
    mBio; 2022 Aug; 13(4):e0126722. PubMed ID: 35913160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
    Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
    mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

  • 4. Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.
    Sharma-Chawla N; Sender V; Kershaw O; Gruber AD; Volckmar J; Henriques-Normark B; Stegemann-Koniszewski S; Bruder D
    Infect Immun; 2016 Dec; 84(12):3445-3457. PubMed ID: 27647871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus.
    Chen YY; Huang CT; Li SW; Pan YJ; Lin TL; Huang YY; Li TH; Yang YC; Gong YN; Hsieh YC
    J Biomed Sci; 2021 Aug; 28(1):60. PubMed ID: 34452635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza a virus and
    Xiang L; Zhou TJ; Zhou LL; Luo J; Qin Z; You JZ; Jian J; Zhao ZY; Zhou YS; Ye YC; Wang HR; Wang BN; Li MY
    J Biol Regul Homeost Agents; 2019; 33(5):1437-1449. PubMed ID: 31637902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus.
    Wolf AI; Strauman MC; Mozdzanowska K; Whittle JR; Williams KL; Sharpe AH; Weiser JN; Caton AJ; Hensley SE; Erikson J
    J Virol; 2014 Oct; 88(20):11995-2005. PubMed ID: 25100838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection.
    Melo EM; Del Sarto J; Vago JP; Tavares LP; Rago F; Gonçalves APF; Machado MG; Aranda-Pardos I; Valiate BVS; Cassali GD; Pinho V; Sousa LP; A-Gonzalez N; Campagnole-Santos MJ; Bader M; Santos RAS; Machado AV; Ludwig S; Teixeira MM
    Pharmacol Res; 2021 Jan; 163():105292. PubMed ID: 33171305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary streptococcal infection following influenza.
    Okahashi N; Sumitomo T; Nakata M; Kawabata S
    Microbiol Immunol; 2022 Jun; 66(6):253-263. PubMed ID: 35088451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune responses at the asymptomatic stage of influenza A viral infections of Streptococcus pneumoniae colonized and non-colonized mice.
    Cuypers F; Schäfer A; Skorka SB; Surabhi S; Tölken LA; Paulikat AD; Kohler TP; Otto SA; Mettenleiter TC; Hammerschmidt S; Blohm U; Siemens N
    Sci Rep; 2021 Oct; 11(1):20609. PubMed ID: 34663857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
    Ivanov S; Renneson J; Fontaine J; Barthelemy A; Paget C; Fernandez EM; Blanc F; De Trez C; Van Maele L; Dumoutier L; Huerre MR; Eberl G; Si-Tahar M; Gosset P; Renauld JC; Sirard JC; Faveeuw C; Trottein F
    J Virol; 2013 Jun; 87(12):6911-24. PubMed ID: 23596287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age.
    Joma BH; Siwapornchai N; Vanguri VK; Shrestha A; Roggensack SE; Davidson BA; Tai AK; Hakansson AP; Meydani SN; Leong JM; Bou Ghanem EN
    Infect Immun; 2021 Jul; 89(8):e0047120. PubMed ID: 34031128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
    Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
    Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.
    Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
    Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN
    mBio; 2019 May; 10(3):. PubMed ID: 31064834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic Influenza Infection Promotes Streptococcus pneumoniae Infiltration, Necrotic Damage, and Proteomic Remodeling in the Heart.
    Platt MP; Lin YH; Wiscovitch-Russo R; Yu Y; Gonzalez-Juarbe N
    mBio; 2022 Feb; 13(1):e0325721. PubMed ID: 35089061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The host transcriptional response to superinfection by influenza A virus and
    Cohn O; Yankovitz G; Mandelboim M; Peshes-Yaloz N; Brandes R; Bacharach E; Gat-Viks I
    mSystems; 2024 Apr; 9(4):e0104823. PubMed ID: 38446104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection.
    Kosai K; Seki M; Tanaka A; Morinaga Y; Imamura Y; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Tomono K; Kohno S
    Jpn J Infect Dis; 2011; 64(6):451-7. PubMed ID: 22116322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus-mediated suppression of bronchial Chitinase-3-like 1 secretion promotes secondary pneumococcal infection.
    Karwelat D; Schmeck B; Ringel M; Benedikter BJ; Hübner K; Beinborn I; Maisner A; Schulte LN; Vollmeister E
    FASEB J; 2020 Dec; 34(12):16432-16448. PubMed ID: 33095949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.